Product information and disease descriptionPlace of product in therapyApproaches to treatment
Heterogeneity of treatment effect
2 evidence topics · 2 sources
HOPE-3: cardiomyopathy subgroup analysis
FDA assessment of the cardiomyopathy definition
Formal treatment-by-subgroup interaction analysis
No evidence found.